Cooke Julie sold $1.5M of NBIX
Cooke Julie (Chief Human Resources Officer) sold 9,521 shares of NEUROCRINE BIOSCIENCES INC (NBIX) at $157.62 ($1.50M total) on 2026-06-02 under a Rule 10b5-1 trading plan.
How this was made
The 30-second read
Why it matters
The event is primarily a transparency/positioning datapoint rather than a catalyst. It can modestly influence short-term sentiment but lacks new fundamental information.
Market read
Traders may treat this as low-signal insider activity; any trading impact is likely minor and short-lived.
What to watch
The disclosure does not state reasons for the sale; without additional context (e.g., size vs. typical pattern, other insiders’ actions), signal quality is limited.
Background
SEC Form 4 reports insider transactions; this one is an open-market sale by the Chief Human Resources Officer, executed under a pre-arranged Rule 10b5-1 plan.
Ticker impact
Neurocrine Biosciences insider disclosure shows HR officer Julie Cooke sold 9,521 shares in an open-market transaction under a 10b5-1 plan.
Low likelihood of a sustained price move; any impact is likely limited to sentiment/flow around the filing window.
The filing is a routine ownership-change disclosure with an explicit pre-arranged 10b5-1 plan, and it does not include new company-specific operating or clinical catalysts.
Market effects
Minimal; single-company Form 4 insider sale without new biotech/clinical/regulatory data.
None indicated.
None indicated.
Counterpoint
Even with a 10b5-1 plan, repeated insider selling can coincide with periods of weaker outlook; traders may still monitor for follow-on sales.
Key entities
- issuerNeurocrine Biosciences, Inc.
Subject of the Form 4 insider transaction disclosure (NBIX).
- insiderJulie Cooke
Chief Human Resources Officer who sold 9,521 shares on 2026-06-02 under a 10b5-1 plan.
